Statistics

Total Visits

Views
Sustained efficacy of ustekinumab in refractory erythrodermic psoriasis after failure of antitumor necrosis factor therapies41

Select a period of time:

Number of views in the range

Views
Sustained efficacy of ustekinumab in refractory erythrodermic psoriasis after failure of antitumor necrosis factor therapies22

Views

Views
October 20240
November 20241
December 20240
January 20255
February 20252
March 202514
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore18
United States3
Canada1
 

Top cities views

Views
Los Angeles2
Pasadena1
Toronto1